Article info

Download PDFPDF
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions
  1. Correspondence to:
 Dr J L Jones, Breast Cancer Research Unit, Department of Pathology, University of Leicester, Glenfield Hospital, Groby Road, Leicester LE2 2BB, UK; 
 lj17{at}le.ac.uk
View Full Text

Citation

Chauhan H, Abraham A, Phillips JRA, et al
There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions

Publication history

  • Accepted December 8, 2002
  • First published April 1, 2003.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.